Multidisciplinary management for primary uterine osteosarcoma, including gene panel testing: case report and literature review

Int Cancer Conf J. 2023 May 9;12(4):241-247. doi: 10.1007/s13691-023-00613-x. eCollection 2023 Oct.

Abstract

Primary osteosarcoma of the uterus (uOS) is rare, and its standard treatment has not yet been established. Herein, we present the case of a 50-year-old woman with uOS who demonstrated an improved prognosis after multiple surgeries to the metastatic sites. After the initial diagnosis of uOS, the patient showed recurrence and distant metastasis and hence expected to exhibit a poor prognosis. The patient underwent multiple surgical resections of the metastatic as well as primary tumors, which enabled the patient to survive for 24 months after the initial surgery. Considering that the median survival time of patients with uOS is approximately 6 months, the survival rate of our patient is noteworthy. Based on our observations, it is suggested that the resection of the primary and metastatic tumors might contribute to the extension of the survival period of the patient with chemo-resistant uOS.

Keywords: Extraskeletal osteosarcoma; Primary osteosarcoma of the uterus; Prognosis; Surgery.